Speeple News Search

Sign Up! | Tags | Domains | Statistics | Options | Advanced Search

Tags » Oxford Bioscience Partners

Related tags: biotech, boston, boston blog main, deals, life sciences, national blog main, roundup, seattle, seattle blog main, vc

  1. Brightcove Bonds with Conde Nast, BSX Backs Brain-Implant Firm, $8 Million Shared With PeerApp, & More Boston-Area Deals News

    xconomy.com » Xconomy Venture Capital Feed - 10 hours ago

    Roundup, deals, VC Rebecca Zacks wrote: The theme for the week was definitely video, with four different deals cut around different aspects of the technology (five, if you count all the video-playing gizmos that cycle …

    Also tagged: video, software, web, roundup, biotech, vc, boston, deals, brightcove, startups, intel capital, first round capital, gazelle, boston scientific, transpera, second rotation, labrador ventures, atlas venture, peerapp, boston blog main, national blog main, flybridge capital partners, 406 ventures, pilot house ventures, cedar fund, third rock ventures, rockport capital partners, evergreen venture partners, safeguard scientifics, zafgen, digitalsmiths, the aurora funds, chrysalis ventures, henry vogel, austin ligon, micrologic, startrak systems, molecular biometrics, intelect medical, digitalarbor, conde nast publications, alanco technologies

  2. Brightcove Bonds with Conde Nast, BSX Backs Brain-Implant Firm, $8 Million Shared With PeerApp, & More Boston-Area Deals News

    xconomy.com » Xconomy - 15 hours ago

    Roundup, deals, VC Rebecca Zacks wrote: The theme for the week was definitely video, with four different deals cut around different aspects of the technology (five, if you count all the video-playing gizmos that cycle …

    Also tagged: video, software, web, roundup, biotech, vc, boston, deals, brightcove, startups, intel capital, first round capital, gazelle, boston scientific, transpera, second rotation, labrador ventures, atlas venture, peerapp, boston blog main, national blog main, flybridge capital partners, 406 ventures, pilot house ventures, cedar fund, third rock ventures, rockport capital partners, evergreen venture partners, safeguard scientifics, zafgen, digitalsmiths, the aurora funds, chrysalis ventures, henry vogel, austin ligon, micrologic, startrak systems, molecular biometrics, intelect medical, digitalarbor, conde nast publications, alanco technologies

  3. Shire Settles TKT Suit, Roche and Ensemble Together Again, BSX Backs Neuromodulation Startup, & More Boston-Area Life Sciences News

    xconomy.com » Xconomy - Nov 13, 2008

    Roundup, Life Sciences, VC Rebecca Zacks wrote: Will “stapled peptides” be the next RNAi? This and other highlights from the last week in Boston-area life sciences news below. —Former shareholders of Cambridge …

    Also tagged: legal, roundup, vc, boston, thermo fisher scientific, deals, startups, harvard medical school, acquisitions, roche, shire, life sciences, boston scientific, dana farber cancer institute, boston blog main, national blog main, transkaryotic therapies, neurotech pharmaceuticals, epivax, molecular biometrics, ensemble discovery, raymond a lamb, aileron therapeutics

  4. Shire Settles TKT Suit, Roche and Ensemble Together Again, BSX Backs Neuromodulation Startup, & More Boston-Area Life Sciences News

    xconomy.com » Xconomy Life Sciences Feed - Nov 12, 2008

    Roundup, Life Sciences, VC Rebecca Zacks wrote: Will “stapled peptides” be the next RNAi? This and other highlights from the last week in Boston-area life sciences news below. —Former shareholders of Cambridge …

    Also tagged: legal, roundup, vc, boston, thermo fisher scientific, deals, startups, harvard medical school, acquisitions, roche, shire, life sciences, boston scientific, dana farber cancer institute, boston blog main, national blog main, transkaryotic therapies, neurotech pharmaceuticals, epivax, molecular biometrics, ensemble discovery, raymond a lamb, aileron therapeutics

  5. Molecular Biometrics Snags $12M For IVF Procedure

    xconomy.com » Xconomy Boston - Nov 11, 2008

    Biotech, Diagnostics, In Vitro Fertilization Luke Timmerman wrote: Molecular Biometrics has raised $12 million in a Series A round of venture capital from Boston-based Oxford Bioscience Partners and Safeguard …

    Also tagged: diagnostics, biotech, boston, life sciences, in vitro fertilization, boston briefs, safeguard scientifics, molecular biometrics

  6. Molecular Biometrics Snags $12M For IVF Procedure

    xconomy.com » Xconomy - Nov 10, 2008

    Biotech, Diagnostics, In Vitro Fertilization Luke Timmerman wrote: Molecular Biometrics has raised $12 million in a Series A round of venture capital from Boston-based Oxford Bioscience Partners and Safeguard …

    Also tagged: diagnostics, biotech, boston, life sciences, in vitro fertilization, boston briefs, safeguard scientifics, molecular biometrics

  7. Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career”

    Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career”

    xconomy.com » Xconomy - Oct 12, 2008

    Biotech, Leroy Hood, Institute for Systems Biology Luke Timmerman wrote: It’s hard to believe Leroy Hood—a guy busy enough to employ not one, but two full-time executive assistants—is turning 70 today. But it’s true …

    Also tagged: bill gates, seattle, hillary clinton, biotech, starbucks, applied biosystems, luxembourg, stanford, multiple sclerosis, bank of america, university of washington, h5n1, caltech, harvard, flu, national institutes of health, charles darwin, university of virginia, life sciences, lemelson mit prize, rheumatoid arthritis, kyoto prize, baylor medical center, human genome project, lake union, seattle art museum, national blog main, seattle blog main, leroy hood, george church, buerk dale victor, institute for systems biology, irving weissman, david galas, integrated diagnostics, swedish neuroscience institute, complete genomics, alan aderem, tim hunkapiller, lasker award amgen, valerie logan, artie buerk, rosetta inpharmatics, cathryn campbell, reudi aebersold, doug fambrough, shurgard storage, gary raisl, essential baking company, paul kearney
  8. Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career”

    Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career”

    xconomy.com » Xconomy Life Sciences Feed - Oct 11, 2008

    Biotech, Leroy Hood, Institute for Systems Biology Luke Timmerman wrote: It’s hard to believe Leroy Hood—a guy busy enough to employ not one, but two full-time executive assistants—is turning 70 today. But it’s true …

    Also tagged: bill gates, seattle, hillary clinton, biotech, starbucks, applied biosystems, luxembourg, stanford, multiple sclerosis, bank of america, university of washington, h5n1, caltech, harvard, flu, national institutes of health, charles darwin, university of virginia, life sciences, lemelson mit prize, rheumatoid arthritis, kyoto prize, baylor medical center, human genome project, lake union, seattle art museum, national blog main, seattle blog main, leroy hood, george church, buerk dale victor, institute for systems biology, irving weissman, david galas, integrated diagnostics, swedish neuroscience institute, complete genomics, alan aderem, tim hunkapiller, lasker award amgen, valerie logan, artie buerk, rosetta inpharmatics, cathryn campbell, reudi aebersold, doug fambrough, shurgard storage, gary raisl, essential baking company, paul kearney
  9. Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career”

    Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career”

    xconomy.com » Xconomy Seattle - Oct 10, 2008

    Biotech, Leroy Hood, Institute for Systems Biology Luke Timmerman wrote: It’s hard to believe Leroy Hood—a guy busy enough to employ not one, but two full-time executive assistants—is turning 70 today. But it’s true …

    Also tagged: bill gates, seattle, hillary clinton, biotech, starbucks, applied biosystems, luxembourg, stanford, multiple sclerosis, bank of america, university of washington, h5n1, caltech, harvard, flu, national institutes of health, charles darwin, university of virginia, life sciences, lemelson mit prize, rheumatoid arthritis, kyoto prize, baylor medical center, human genome project, lake union, seattle art museum, national blog main, seattle blog main, leroy hood, george church, buerk dale victor, institute for systems biology, irving weissman, david galas, integrated diagnostics, swedish neuroscience institute, complete genomics, alan aderem, tim hunkapiller, lasker award amgen, valerie logan, artie buerk, rosetta inpharmatics, cathryn campbell, reudi aebersold, doug fambrough, shurgard storage, gary raisl, essential baking company, paul kearney

  10. British Biotech Antisoma Sees Buyout of Xanthus as Beginning of U.S. Commercial Hub in Cambridge, MA

    xconomy.com » Xconomy Boston - Sep 9, 2008

    Life Sciences, deals, Antisoma Ryan McBride wrote: Glyn Edwards, CEO of British biotech firm Antisoma, has found just the tonic for both the particularly gloomy weather in London this year and the business risk his …

    Also tagged: boston, deals, novartis, cambridge, life sciences, antisoma, boston blog main, national blog main, healthcare ventures, xanthus pharmaceuticals, michael lytton, still river funds, glyn edwards

1  2  3